Gastroenterology and Hepatology

Medicine & Life Sciences

1. Liver Transplantation 100%
2. Barrett Esophagus 80%
3. Liver 79%
4. Irritable Bowel Syndrome 72%
5. Inflammatory Bowel Diseases 70%
6. Crohn Disease 65%
7. Sclerosing Cholangitis 65%
8. Celiac Disease 61%
9. Neoplasms 59%
10. Therapeutics 57%
11. Cholangiocarcinoma 53%
12. Fibrosis 51%
13. Liver Diseases 48%
14. Hepatocellular Carcinoma 44%
15. Colorectal Neoplasms 44%
16. Constipation 43%
17. Gastric Emptying 42%
18. Stomach 40%
19. Pancreatic Neoplasms 40%
20. Endoscopy 38%
21. Hepatocytes 37%
22. Adenocarcinoma 37%
23. Survival 33%
24. Non-alcoholic Fatty Liver Disease 33%
25. Bile Acids and Salts 32%
26. Gastroparesis 32%
27. Gastrointestinal Diseases 30%
28. Diarrhea 30%
29. Biopsy 30%
30. Colon 29%
31. Population 29%
32. Gastroesophageal Reflux 29%
33. Biliary Liver Cirrhosis 29%
34. Eosinophilic Esophagitis 27%
35. Confidence Intervals 27%
36. Apoptosis 27%
37. Placebos 26%
38. End Stage Liver Disease 25%
39. Pancreatitis 25%
40. Colonoscopy 24%
41. Systematic Reviews 24%
42. Safety 24%
43. Autoimmune Pancreatitis 23%
44. Bile Ducts 23%
45. Hemorrhage 23%
46. Mortality 23%
47. Genes 23%
48. Gastroenterology 23%
49. Proteins 22%
50. Obesity 22%
51. Incidence 22%
52. Inflammation 21%
53. Meta-Analysis 20%
54. Colonic Neoplasms 20%
55. Dyspepsia 20%
56. Biomarkers 20%
57. Recurrence 20%
58. Serum 19%
59. Manometry 19%
60. Portal Hypertension 18%
61. Infections 18%
62. Epidemiology 18%
63. Pathologic Constriction 18%
64. Hepacivirus 17%
65. Chronic Pancreatitis 17%
66. Esophagus 17%
67. Microbiota 17%
68. Glutens 17%
69. Liver Cirrhosis 17%
70. Hepatitis C 16%
71. Wounds and Injuries 16%
72. Elasticity Imaging Techniques 16%
73. Dynamins 16%
74. Bile 16%
75. Microscopic Colitis 16%
76. Transplant Recipients 15%
77. Odds Ratio 15%
78. Mutation 15%
79. Gastroenterologists 15%
80. Abdominal Pain 15%
81. Pressure 15%
82. Pharmaceutical Preparations 15%
83. Cohort Studies 15%
84. Alcoholic Hepatitis 15%
85. Transplants 15%
86. Fecal Incontinence 15%
87. Gastrointestinal Microbiome 14%
88. Phenotype 14%
89. Gastrointestinal Motility 14%
90. Esophageal Neoplasms 14%
91. Gastrointestinal Tract 14%
92. Polyps 14%
93. Colitis 14%
94. Mucous Membrane 14%
95. Stents 13%
96. Randomized Controlled Trials 13%
97. vedolizumab 13%
98. Endoscopic Retrograde Cholangiopancreatography 13%
99. Transplantation 13%